3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
4
Lymphoma, Large B-Cell, Diffuse
3
Lymphoma, B-Cell, Marginal Zone
2
Carcinoma, Non-Small-Cell Lung
2
Recurrence
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Neoplasms
1
Lymphoma, Mantle-Cell
1
Lymphoma, Follicular
1
Lymphoma, B-Cell
1
Lung Neoplasms
1
Locally Recurrent Skin Squamous Cell Carcinoma
1
Leukemia, Plasma Cell
1
Endometrial Neoplasms
1
Clear-cell metastatic renal cell carcinoma
1
Classic Follicular Lymphoma
1
Carcinoma, Renal Cell
1
Interventions
venetoclax
69
Cyclophosphamide
53
ibrutinib
45
obinutuzumab
43
acalabrutinib
43
Rituximab
40
fludarabine
37
fludarabine phosphate
30
Specimen Handling
29
pirtobrutinib
26
Biopsy
24
zanubrutinib
23
Whole-Body Irradiation
16
Bendamustine Hydrochloride
15
Magnetic Resonance Spectroscopy
14
Mycophenolic Acid
13
Lenalidomide
11
Peripheral Blood Stem Cell Transplantation
9
Sirolimus
8
idelalisib
7
Tacrolimus
7
CT-P10
7
ARQ531
7
tafasitamab
6
Prednisone
6
Busulfan
6
pembrolizumab
5
Stem Cell Transplantation
5
Melphalan
5
Interleukin-2
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia, Lymphocytic, Chronic, B-Cell
×
Hyaluronoglucosaminidase
×
1 year
×
Clear all
No trials found.